NHC stock may face bearish pressure due to its recent rally following strong Q3 results, which could lead to profit-taking. The stock's valuation appears stretched after a significant earnings jump, with EPS rising to $2.73, but future growth sustainability remains uncertain. Additionally, the healthcare sector's regulatory risks and potential cost pressures could weigh on investor sentiment.